Skip to content

Evaluation of the Mat Pilates Method on mental health and on the quality of life of university students: a Randomized Clinical Trial

Effects of a mat Pilates Method exercise protocol on the mental health and quality of life of university students: a Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8xzpdbc
Enrollment
Unknown
Registered
2023-05-25
Start date
2022-09-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress, Psychological

Interventions

This is a two-arm, single-blind, randomized controlled clinical trial. Participants will be invited to participate in the study and will fill out: Free and Informed Consent Form
Form containing sociodemographic and clinical questions
the Depression, Anxiety and Stress Scale (DASS-21) and the World Health Organization (WHOQOL–bref) instrument for assessing quality of life. Then, the subjects will be randomized to compose the experi
the DASS-21 Scale and the WHOQOL–bref instrument. The application of the questionnaires will be carried out by a researcher blinded to the intervention.
E02.779.474

Sponsors

Universidade Federal do Triângulo Mineiro
Lead Sponsor
Universidade Federal do Triângulo Mineiro
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: University students regularly enrolled in undergraduate courses in the health area at UFTM, who have attended at least two consecutive terms; Age equal to or greater than 18 years; Not having been pregnant or giving birth in the last six months; Not having had previous contact with the Pilates Method in the last three month.

Exclusion criteria

Exclusion criteria: Having a health problem that makes intervention impossible: musculoskeletal injury, pathology or structural deformity linked to the spine or upper and lower limbs; Systemic disease including rheumatological, metabolic or inflammatory; Present chronic pain at the time of assessment; Having used anxiolytics/antidepressants in the three months prior to the study.

Design outcomes

Secondary

MeasureTime frame
Normal scores for quality of life measured by the WHOQOL–bref instrument.

Primary

MeasureTime frame
Normal scores for depression, anxiety and stress measured by the Depression, Anxiety and Stress Scale (DASS-21).

Countries

Brazil

Contacts

Public ContactAdriana Nicolussi

Universidade Federal do Triângulo Mineiro

adriana.nicolussi@uftm.edu.br+55-34-37006706

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 14, 2026